Open-label, randomised controlled, multicentre study evaluating higher valency pneumococcal vaccines (PCV15/PCV20) compared with PCV13 given in homologous schedules at 3 months and 12 months ('1+1' schedule) and 2 months, 4 months and 12 months ('2+1' schedule) in infants: protocol.

Aslam R, Akeju O, Clutterbuck E, Appleby C, Murphy D, De Calignon A, Muller J, White R, Singha A, Mujadidi YF, Roderick M, Turner DPJ, Heath PT, Owens D, Goldblatt D, Ebrahimi N, Liu X, Faust S, Ramasamy MNN, Kelly D.

Open source

DOI: 10.1136/bmjopen-2025-116062
Published: 2026-09-22
Container: BMJ Open
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2025-116062,
  title = {Open-label, randomised controlled, multicentre study evaluating higher valency pneumococcal vaccines (PCV15/PCV20) compared with PCV13 given in homologous schedules at 3 months and 12 months ('1+1' schedule) and 2 months, 4 months and 12 months ('2+1' schedule) in infants: protocol.},
  author = {Aslam R and  Akeju O and  Clutterbuck E and  Appleby C and  Murphy D and  De Calignon A and  Muller J and  White R and  Singha A and  Mujadidi YF and  Roderick M and  Turner DPJ and  Heath PT and  Owens D and  Goldblatt D and  Ebrahimi N and  Liu X and  Faust S and  Ramasamy MNN and  Kelly D.},
  year = {2026},
  journal = {BMJ Open},
  doi = {10.1136/bmjopen-2025-116062},
  url = {https://doi.org/10.1136/bmjopen-2025-116062}
}

RIS

TY  - JOUR
TI  - Open-label, randomised controlled, multicentre study evaluating higher valency pneumococcal vaccines (PCV15/PCV20) compared with PCV13 given in homologous schedules at 3 months and 12 months ('1+1' schedule) and 2 months, 4 months and 12 months ('2+1' schedule) in infants: protocol.
AU  - Aslam R
AU  -  Akeju O
AU  -  Clutterbuck E
AU  -  Appleby C
AU  -  Murphy D
AU  -  De Calignon A
AU  -  Muller J
AU  -  White R
AU  -  Singha A
AU  -  Mujadidi YF
AU  -  Roderick M
AU  -  Turner DPJ
AU  -  Heath PT
AU  -  Owens D
AU  -  Goldblatt D
AU  -  Ebrahimi N
AU  -  Liu X
AU  -  Faust S
AU  -  Ramasamy MNN
AU  -  Kelly D.
PY  - 2026
JO  - BMJ Open
DO  - 10.1136/bmjopen-2025-116062
UR  - https://doi.org/10.1136/bmjopen-2025-116062
ER  -

APA

R, A., O, A., E, C., C, A., D, M., A, D. C., J, M., R, W., A, S., YF, M., M, R., DPJ, T., PT, H., D, O., D, G., N, E., X, L., S, F., MNN, R., & D., K. (2026). Open-label, randomised controlled, multicentre study evaluating higher valency pneumococcal vaccines (PCV15/PCV20) compared with PCV13 given in homologous schedules at 3 months and 12 months ('1+1' schedule) and 2 months, 4 months and 12 months ('2+1' schedule) in infants: protocol.. BMJ Open. https://doi.org/10.1136/bmjopen-2025-116062

Source records

europe-pmc · retrieved 2026-09-25T16:34:24.098Z
doaj · retrieved 2026-09-25T16:34:24.078Z